MedPath

Optical Coherence Tomography and Optic Neuritis (OCTON)

Completed
Conditions
Optical Neuritis
Registration Number
NCT02573792
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

Optic neuritis (ON) can remain isolated or reveal a widespread and chronic disease of the central nervous system (CNS), a multiple sclerosis (MS) or, more rarely, a Devic's neuromyelitis optica (NMO) or a systemic disease.

The optical coherence tomography (OCT) is a retinal imaging technique to measure the thickness of the retina and its different layers with an accuracy of 4-6 µM.

Costello et al have shown that approximately 75% of 54 MS patients have developed within 3 to 6 months after a ON a loss of 10 to 40 µM in the thickness of the peripapillary retinal nerve fiber layer (RNFL).

The etiologic diagnosis of ON has been transformed in recent years. MS can now be diagnosed by McDonald's MRI criteria and NMO by the AQP4 antibodies (anti-aquaporin- 4) antibodies and the anti-MOG (myelin-oligodendrocyte glycoprotein) antibodies.

The diagnosis and prognosis value of the OCT in patients with ON is not well known

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • first onset of an optical neuritis lasting for less than 3 months
Exclusion Criteria
  • Contra-indication to MRI
  • Patient opposed to participation in the study
  • Pregnant or lactating woman
  • Patient under a measure of legal protection
  • Absence of affiliation to social security or universal health coverage (CMU)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity of the OCT, expressed as a percentage, for the etiological diagnosis of optical neuritisOne year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondation Ophtalmologique Adolphe de Rothschild

🇫🇷

Paris, Ile De France, France

© Copyright 2025. All Rights Reserved by MedPath